mesothelioma
The mTOR inhibitor temsirolimus is active against mesothelioma in vitro and in vivo and synergizes with chemotherapy.
The <span class="gene" id="21358348-11-4-8">mTOR</span> inhibitor temsirolimus is active against <span class="disease" id="21358348-11-50-62">mesothelioma</span> in vitro and in vivo and synergizes with chemotherapy.